Medical Oncologist specialising in urological cancers at Monash Cancer Centre. Clinical trial investigator and prostate cancer translational researcher.
Joined November 2012
- Tweets290
- Following144
- Followers324
- Likes120
David Pook retweeted
Great to see @ANZUPtrials #UNICAB Study poster @ASCO #GU24 presented by @docpook. Well done to entire team for their ongoing hard work #kidneycancer #improvingoutcomes #BaCT @PeterMacCC @IpsenGroup @CancerAustralia @DrCraigGedye @Prof_IanD
David Pook retweeted
Delving into the ENZAMET trial: Radiographic progression in mHSPC may occur without PSA elevation, challenging conventional monitoring methods. The study underscores the complexity of disease progression. #ProstateCancer
@Prof_IanD @ChrisSweens1
@ASCO #GU24 @OncoAlert @urotoday @oncodaily @DrChoueiri @yekeduz_emre @sophia_kamran @BraunMDPhD @AmandaNizamMD @TiansterZhang @RCCadvocate @ShuchiGulati @RuchikaTalwarMD @DrKarineTawagi @neerajaiims @montypal @crisbergerot @DrRanaMcKay @Tilki_De @CParkMD @cdanicas @FabioSchutz78 @PGrivasMDPhD
David Pook retweeted
Great @ANZUPtrials poster @ASCO #GU24 Baseline disease characteristics of participants enrolled on #ENZARAD & #DASLHiCaP Congrats @niazi_Dr7 @ChrisSweens1 @DrPaulNguyen & Scott Williams @TrialsCentre @ThePCCTC @cancertrials_ie @CDNCancerTrials @MSKCancerCenter @AstellasUS @Bayer
David Pook retweeted
JUST IN: some news in metastatic bladder cancer combinations via @Reuters
reut.rs/46Gga8h reut.rs/46Gga8h
David Pook retweeted
Gem/cis & nivolumab achieves significant PFS & OS in 1st line UC . Maintenance avelumab = 25% ⬆️ in OS, but not all pts get there. Better disease control during the chemo phase and competitive OS HR will be attractive to patients. news.bms.com/news/corporate-…
David Pook retweeted
Pleased to share @TheLancetOncol LENVA-PEMBRO across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim @myESMO #ESMO22 and final @ChungHanLee3 @ASCO #ASCO23
full text: authors.elsevier.com/a/1hP1c…
Thanks to all who change
rareRCC pts Tx! – at Paris, France
David Pook retweeted
Liz Liow presenting KRAB data (Australian real world kidney cancer data) @ANZUPtrials #ANZUP23 at best of the best oral abstract session @WEHI_research @DrDanielHeng
David Pook retweeted
#ANZUP23 ASM is happening tomorrow! This is your final opportunity to register for the premier GU cancer meeting in the region. Secure your spot now at anzup.org.au/registration-2/. We look forward to seeing you at Melbourne Convention Centre.
David Pook retweeted
New to the #ANZUP23 ASM, The Perfect Pitch workshop is chaired by @_ShankarSiva and @ciaraconduit. It is designed to discuss how to pitch an idea and how to bring new concepts forward for idea development, which could potentially move on to a fully fledged clinical trial.
David Pook retweeted
Now online @CCR_AACR - Phase IB study ipatasertib plus rucaparib in mCR #prostatecancer post-NHA. No evidence of synergistic or additive antitumor activity. No clear signal of benefit in biomarker +ve populations either
My take: Still no role for targeting PI3K pathway in mCRPC
David Pook retweeted
Dr David Pook @docpook on hot topics from 2022: more is not always better, when more drugs does not mean better outcomes | Best of GU Evening Symposium | @ANZUPtrials @USANZUrology @ANZUNS_Urology
David Pook retweeted
Good to see insights on management of prostate cancer from Prof Lisa Hovarth, A/Prof Jeff Goh and @docpook.
David Pook retweeted
ANZUP Trials in Action. Hear from @ANZUPtrials BUP, prostate, renal, testicular, & QoL chairs & deputy chairs providing updates & future trial possibilities with Lisa Horvath, @DocJarad, Dickon Hayne, @DrCraigGedye, @docpook, @DrBenTran, @pattibastick, @hagsie & @ProfCancerCare
David Pook retweeted
The ENZAMET (Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic #ProstateCancer) trial investigated the effects of adding enzalutamide to first-line treatment that included testosterone suppression with or without early docetaxel. #ASCO19
David Pook retweeted
#ENZAMET:
Slides available here on @ANZUPtrials web site: anzup.org.au/docview.aspx?id…
Paper here: nejm.org/doi/full/10.1056/NE… @NEJM
Thanks to the cast of thousands @ChrisSweens1 @TrialsCentre @CDNCancerTrials @cancertrials_ie @DanaFarber☝️and our selfless patients.
#ASCO19
David Pook retweeted
Great conference, learned a lot, Australians are great! #ANZUP17
David Pook retweeted
No need to do renal mass biopsy in patient if planning AS anyway @uretericbud #ANZUP17
